The TMC team is led from our UK offices by the company's founders
Julie Matthews - Chief Executive Officer and VP Operations
Trained in microbiology, Julie ran an academic hospital research laboratory in Cambridge (UK) prior to joining Warner Lambert Clinical Development Group in 1986, where she ultimately became International Therapy Area Director. She then joined Rhone Poulenc Rorer in France, where she was involved first in oncology clinical development, and subsequently as Head of Anti-infectives Clinical Development.
Julie then joined Orphan Europe in Paris as Head of Clinical Development and Regional Business Manager, before going on to set up and run the company's UK affiliate, as General Manager responsible for drug and business development, regulatory affairs, sales and marketing. Julie started TMC in the year 2000.
Work for usDr Mike Matthews, MB ChB - Chief Medical Officer
After taking his medical degree at the University of Birmingham (UK) Mike worked in the UK Health and Safety Executive in infection control in hospitals and research labs, before joining the pharmaceutical industry in 1986. Since then, he has worked with ICI Pharmaceuticals HQ (now AstraZeneca) in the UK; Adelphi Communications (UK); Sanofi Recherche HQ (France); ADIS International (UK); ICON Clinical Research (as Director of Medical Affairs, Europe, based in the UK). Mike has also acted as an independent consultant to both major pharmaceutical and niche biotech companies. Mike joined TMC in 2001.
Nicola Kidman – Director of Regulatory and Clinical Services
After graduating from The University of Reading (UK) in 1999 with a degree in Pathobiology, Nicola joined Aventis Pharma where she was responsible for regulatory management of a portfolio products registered via national, mutual recognition and centralised procedures. In 2004, Nicola moved to Orion Clinical Services as Regulatory Affairs Manager and then in late 2005 to Parexel Consulting, the regulatory consulting division of Parexel International Ltd. During her time at Parexel she held a number of roles, including management of the UK Clinical Trial Regulatory Team and later responsibility for the UK Consulting team of approximately 30 staff providing European and Worldwide regulatory consulting covering all aspects of drug development. Nicola Joined TMC in March 2011.
Dr Susan Tansey MB ChB, MRCP, MRCPCH, MFPM – Director of Medical Services
Sue qualified in medicine at The University of Manchester (UK) in 1988 and spent a further ten years training in internal medicine and paediatrics in the UK National Health Service and in various University posts. Sue moved into the pharmaceutical industry in 1998 joining Servier’s UK R&D department where she worked on clinical trials (phases 1 to 4) and was promoted to Clinical Research Manager. In 2005 Sue joined Pfizer (formerly Wyeth) as Associate Director (and was subsequently Director) in Vaccine Research. She was responsible for vaccine clinical trials in Europe, the US and China and was part of the regulatory submission team for Europe and the US. She is on the UK specialist register as Consultant Pharmaceutical Physician, is Associate Director for Industry on the Medicines for Children Research Network and is active in the Royal College of Physicians’ Faculty of Pharmaceutical Medicine. Sue joined TMC in June 2011.
